Sleep Dysfunction in Movement Disorders: a Window to the Disease Biology

Area of Science:

• Neurology
• Sleep Medicine
• Neurodegeneration

Background:

• Sleep and circadian rhythm disruption are increasingly linked to the pathophysiology of movement disorders.
• Poor sleep quality and circadian dysfunction can worsen neurodegeneration.
• Anti-IgLON5 disease is an autoimmune disorder with significant sleep disruption and parasomnia.

Purpose of the Study:

• To summarize sleep pathologies in movement disorders, with a focus on neurodegenerative conditions.
• To review the mechanisms linking sleep disruption to neurodegeneration.
• To highlight the importance of screening for and managing sleep symptoms in patients with movement disorders.

Main Methods:

• Literature review of studies on sleep disorders and movement disorders.
• Analysis of recent findings on the interplay between sleep, circadian rhythms, and neurodegeneration.
• Inclusion of emerging autoimmune conditions like anti-IgLON5 disease.

Main Results:

• Movement disorders frequently involve sleep and circadian rhythm disruption.
• Motor symptoms contribute to sleep fragmentation, leading to insomnia and excessive daytime sleepiness.
• Brainstem pathology in neurodegenerative movement disorders can affect sleep-wake regulatory nuclei.
• Medications for movement disorders can exacerbate sleep problems.

Conclusions:

• Sleep and circadian disruption are integral to the progression of many movement disorders.
• Recognizing and treating sleep pathologies can significantly improve patient and caregiver quality of life.
• Comprehensive management of movement disorders should include addressing sleep-related symptoms.